549 results
8-K
EX-10.1
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably … ) Accountants. The Company’s independent registered accounting firm is KPMG LLP. To the knowledge and belief of the Company, such accounting firm (i
8-K
EX-4.1
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers … Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
8-K
EX-10.2
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
of the Company’s counsel, independent public or certified public accountants and other advisors; (v) all costs and expenses incurred in connection
8-K
EX-5.1
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
the generality of the foregoing, in our examination, we have, with your permission, assumed without independent verification: (i) the statements of fact
8-K
EX-5.2
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
the opinions expressed below, we have assumed, without independent investigation or verification: (i) the genuineness of all signatures on all
8-K
EX-4.2
rr40id97bg2r6h
21 May 24
Entry into a Material Definitive Agreement
4:01pm
424B5
p68hzoh1fasy805 s2
20 May 24
Prospectus supplement for primary offering
4:16pm
424B3
gxex1u fr1l86
15 Mar 24
Prospectus supplement
4:15pm
S-8
EX-23.1
up8ekafvjtxdf8o
6 Mar 24
Registration of securities for employees
5:38pm
S-8
2emxlfcb4e 92ac9
6 Mar 24
Registration of securities for employees
5:38pm
S-8
EX-5.1
wane j1g4lw
6 Mar 24
Registration of securities for employees
5:38pm